Clinical trial

Alcoholism and Schizophrenia: Effects of Clozapine

NCT00169026

StatusTERMINATED

Study typeINTERVENTIONAL

Start date1999-05-01

PhasePHASE4

Study timeline

Study start (unknown)1999-05-01Date precision: month

Registry last updated2018-03-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Dual Diagnosisunresolved

Schizoaffective Disorderunresolved

Psychotic Disorderunresolved

Substance Abuseunresolved

Alcohol Abuseunresolved

Interventions

Clozapine versus typical (conventional) and atypical antipsychotic medicationsDRUG

Sponsors & collaborators

Dartmouth-Hitchcock Medical Centerlead sponsor

National Institute on Alcohol Abuse and Alcoholism (NIAAA)collaborator

Harvard Medical School (HMS and HSDM)collaborator

Commonwealth Research Center, Massachusettscollaborator

Novartiscollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00169026 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.